压缩器雾化吸入与氧气雾化吸入在肺癌患者围术期的应用观察

Application of Compressor Atomization Inhalation and Oxygen Atomization Inhalation in Perioperative Period of Lung Cancer Patients

目的:分析接受手术的肺癌患者在围术期采用氧气雾化吸入和压缩器雾化吸入治疗的临床效果。方法:选择2017年1月-2018年11月在笔者所在医院接受手术治疗的72例肺癌患者,以随机分组法将其分为对照组(36例)和治疗组(36例)。对照组在围手术期接受氧气雾化吸入治疗;治疗组在围手术期接受压缩器雾化吸入治疗。比较两组治疗效果、呼吸状态恢复正常时间和术后住院时间、不良反应发生情况、血氧饱和度、排痰量、生活质量、围手术期辅助治疗方案满意度。结果:治疗组患者治疗总有效率为91.7%,高于对照组的69.4%,差异有统计学意义(P<0.05)。治疗组呼吸状态恢复正常时间(7.10±1.54)d,早于对照组的(10.79±2.27)d,术后住院时间(10.22±2.07)d,短于对照组的(14.63±2.15)d,差异均有统计学意义(P<0.05)。治疗组围手术期不良反应发生率2.8%,低于对照组的16.7%,差异有统计学意义(P<0.05)。治疗组血氧饱和度、排痰量、生活质量评分均优于对照组,差异有统计学意义(P<0.05)。治疗组围手术期辅助治疗方案满意度为94.4%,高于对照组的80.6%,差异有统计学意义(P<0.05)。结论:接受手术治疗的肺癌患者在围手术期采用压缩器雾化吸入方式进行治疗,可以大幅度改善血氧饱和度、排痰量、生活质量,减少相关不良反应,缩短恢复和住院时间,从而使雾化治疗效果和满意度得到显著提高。

Objective:To analyze the clinical effects of oxygen atomization inhalation and compressor atomization inhalation in patients with lung cancer undergoing operation during perioperative period.Method:A total of 72 patients with lung cancer who underwent surgery in our hospital from January 2017 to November 2018 were selected and randomly divided into control group(36 cases) and treatment group(36 cases).The control group received oxygen atomization inhalation during the perioperative period,while the treatment group received compressor atomization inhalation during the perioperative period.The treatment effect,the recovery time of respiratory statu and postoperative hospital stay,adverse reactions,blood oxygen saturation,sputum excretion,quality of life and satisfaction with perioperative adjuvant treatment plan were compared between the two groups.Result:The total effective rate of the treatment group was 91.7%,which was higher than 69.4% of the control group,the difference was statistically significant(P<0.05).The recovery time of respiratory state in the treatment group was(7.10±1.54)d,which was earlier than(10.79±2.27)d in the control group,and the postoperative hospital stay was(10.22±2.07)d,which was shorter than(14.63±2.15)d in the control group,the differences were statistically significant(P<0.05).The incidence of perioperative adverse reactions in the treatment group was 2.8%,which was lower than 16.7% in the control group,the difference was statistically significant(P<0.05).Blood oxygen saturation,sputum excretion and quality of life score of the treatment group were all better than those of the control group,the differences were statistically significant(P<0.05).The satisfaction rate of perioperative adjuvant therapy in the treatment group was 94.4%,which was higher than 80.6% of the control group,the difference was statistically significant(P<0.05).Conclusion:The use of compressor atomization inhalation during perioperative period for lung cancer patients undergoing surgical treatment can significantly improve blood oxygen saturation,sputum excretion,quality of life,reduce related adverse reactions,shorten recovery and postoperative hospital stay,thus significantly improving the efficacy and satisfaction of atomization therapy.